CN103041041B - Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer - Google Patents
Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer Download PDFInfo
- Publication number
- CN103041041B CN103041041B CN201210497914.4A CN201210497914A CN103041041B CN 103041041 B CN103041041 B CN 103041041B CN 201210497914 A CN201210497914 A CN 201210497914A CN 103041041 B CN103041041 B CN 103041041B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- blood
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer. The traditional Chinese medicine comprises the following material components in parts by weight: 13-17 parts of red flowers, 8-12 parts of wikstroemia indica, 10-15 parts of radix trichosanthis, 10-15 parts of hedyotis diffusa, 8-12 parts of leeches, 8-12 parts of peach seeds, 6-10 parts of scutellariae barbatae, 13-17 parts of angelica sinensis, 6-10 parts of Chinese blister beetles roasted with vinegar, 6-10 parts of moringa oleifera roots, 4-8 parts of shinyleaf pricklyash roots, 4-8 parts of radix bupleuri, 13-17 parts of long-noded pit vipers, 6-10 parts of pangolins, 10-15 parts of dried wall lizards and 4-8 parts of white glues. The traditional Chinese medicine disclosed by the invention has the effects of promoting qi to activate blood and dispersing blood stasis and removing food retention, can be used for effectively relieving the pain of the patient and remarkably strengthening the health, the appetite and the immunity of the patient. The cancer cell lesion can be restrained and prevented by taking the medicine for a long time. Besides, the medicine has no toxic and side effect, as well as a better effect for a use after the operation.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type hepatocarcinoma.
background technology:
Day by day serious along with environmental pollution, people are subject to the factors such as chemistry, physics, biology (as smoking, excessive drinking, ionizing radiation and air pollution etc.), and the sickness rate of cancer is more and more higher, and wherein hepatocarcinoma is that China head sees one of malignant tumor.Mortality rate is high, is only second to gastric cancer, esophageal carcinoma and occupies the 3rd in mortality of malignant tumors cis-position, accounts for second in the rural area in area, position.Modern medicine mainly adopts operation, radiation and chemotherapy for the treatment of cancer, but the equal defectiveness of these methods, wherein only have early stage patient just can carry out operative treatment, the means of topical therapeutic when operative treatment, like water off a duck's back for transferring to tumor cell in blood or its hetero-organization, Radiotherapy chemotherapy can effectively be hindered cancerous cell, but can kill and wound normal cell again and cause patient's immunologic function suppressed simultaneously, there is more complication, bring very big damage to patient body.Also there is now the Chinese medicine of some Hepatoma therapies, but be all taking pain relieving, relief of symptoms as main, can not play actual antitumaous effect.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, and a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type hepatocarcinoma is provided, and can suppress and prevent cancerous cell pathological changes.
The present invention is achieved by the following technical solutions:
A Chinese medicine for the treatment of qi stagnation and blood stasis type hepatocarcinoma, is characterized in that: the weight proportion of its each raw material components is: Flos Carthami 13-17, Radix Wikstroemae 8-12, Radix Trichosanthis 10-15, Herba Hedyotidis Diffusae 10-15, Hirudo 8-12, Semen Persicae 8-12, Herba Scutellariae Barbatae 6-10, Radix Angelicae Sinensis 13-17, vinegar stir-baked MYLABRIS with rice 6-10, Moringa root 6-10, Radix Zanthoxyli 4-8, Radix Bupleuri 4-8, Agkistrodon 13-17, Squama Manis 6-10, dry Gekko Swinhonis 10-15, Resina Liquidambaris 4-8.
A Chinese medicine for the treatment of qi stagnation and blood stasis type hepatocarcinoma, is characterized in that: the weight proportion of its each raw material components is: Flos Carthami 15, Radix Wikstroemae 10, Radix Trichosanthis 13, Herba Hedyotidis Diffusae 13, Hirudo 10, Semen Persicae 10, Herba Scutellariae Barbatae 8, Radix Angelicae Sinensis 15, vinegar stir-baked MYLABRIS with rice 8, Moringa root 8, Radix Zanthoxyli 6, Radix Bupleuri 6, Agkistrodon 15, Squama Manis 8, dry Gekko Swinhonis 13, Resina Liquidambaris 6.
In this formula, Semen Persicae, Flos Carthami blood circulation promoting and blood stasis dispelling; Radix Trichosanthis " disappears to flutter and damages blood stasis "; Radix Angelicae Sinensis blood circulation promoting and enriching; Radix Bupleuri circulation of qi promoting is soothing the liver; Squama Manis dredging liver network; Resina Liquidambaris pain relieving.Hirudos etc. are to strengthen the analgesic therapy of invigorating blood circulation, the power of blood stasis dispelling removing food stagnancy.
Advantage of the present invention is:
Chinese medicine of the present invention has promoting flow of QI and blood, effect of blood stasis dispelling removing food stagnancy, effectively reduction of patient pain, and can obviously strengthen patient's body constitution, strengthen patient's appetite, strengthen patient's resistance, long-term taking can suppress and prevent cancerous cell pathological changes, have no side effect, coordinate postoperative use, effect is better.
detailed description of the invention:
Treat a Chinese medicine for qi stagnation and blood stasis type hepatocarcinoma, the weight (g) of its each raw material components is: Flos Carthami 15, Radix Wikstroemae 10, Radix Trichosanthis 13, Herba Hedyotidis Diffusae 13, Hirudo 10, Semen Persicae 10, Herba Scutellariae Barbatae 8, Radix Angelicae Sinensis 15, vinegar stir-baked MYLABRIS with rice 8, Moringa root 8, Radix Zanthoxyli 6, Radix Bupleuri 6, Agkistrodon 15, Squama Manis 8, dry Gekko Swinhonis 13, Resina Liquidambaris 6.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case one:
Wang, man, 42 years old.Main suit: epigastrium dull pain discomfort, become thin, liver pain, epigastrium lay one's hand on enclosed mass 10 days, have a medical check-up: shallow complexion and dim, fatigue and weakness, distension and fullness in the abdomen.Alpha-fetoprotein (AFP) 12500ng, B ultrasonic, CT examination show " left liver occupy-place ", to hospital surgical, see micronodular cirrhosis in art, tumor is positioned at left half intrahepatic leaf, approximately 3 × 5cm size.Postoperatively give Chinese medicine of the present invention and take, after three months, AFP is down to normally, and life work is as usual, strong depositing so far.
Case two:
Money, female, 49 years old.Main suit: before three months, liver pain discomfort, appetite decline, stool disturbance of defecation with either dry or loose stool, menoxenia.Have a medical check-up: color of the leather is greenish yellow, venation exposes.B ultrasonic, CT examination are found " right liver occupy-place ", to hospital surgical, see micronodular cirrhosis in art, and tumor is positioned at right liver upper back, approximately 5 × 6cm size.Pathological replacement is: " hepatocellular carcinoma ".Postoperatively give Chinese medicine of the present invention and take, after four months, AFP is down to normally, Return to work, strong depositing so far.
Case three:
Grandson, man, 54 years old.Main suit: the uncomfortable companion of upper right abdomen dull pain general weakness 2 months, right flank pain is more acute, as cone as thorn, enters Night Watch very.Have a medical check-up: color of the leather is greenish yellow, venation exposes, and purplish tongue has petechia ecchymosis, stringy and hesitant pulse.AFP46.6ng, B ultrasonic, CT examination are found " right liver occupy-place ", to hospital surgical, see that tumor is positioned at right liver caudal lobe in art, approximately 4 × 6cm, near right portal vein trunk and postcava trunk.Pathological replacement is: " hepatocellular carcinoma ".Postoperatively give Chinese medicine of the present invention and take, after five months, AFP is down to normally, lives as usual, strong depositing so far.
Claims (1)
1. a Chinese medicine for the treatment of qi stagnation and blood stasis type hepatocarcinoma, is characterized in that: the weight of its each raw material components is: Flos Carthami 15 g, Radix Wikstroemae 10 g, Radix Trichosanthis 13 g, Herba Hedyotidis Diffusae 13 g, Hirudo 10 g, Semen Persicae 10 g, Herba Scutellariae Barbatae 8 g, Radix Angelicae Sinensis 15 g, vinegar stir-baked MYLABRIS with rice 8 g, Moringa root 8 g, Radix Zanthoxyli 6 g, Radix Bupleuri 6 g, Agkistrodon 15 g, Squama Manis 8 g, dry Gekko Swinhonis 13 g, Resina Liquidambaris 6 g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210497914.4A CN103041041B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210497914.4A CN103041041B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041041A CN103041041A (en) | 2013-04-17 |
CN103041041B true CN103041041B (en) | 2014-08-06 |
Family
ID=48054052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210497914.4A Expired - Fee Related CN103041041B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041041B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815083A (en) * | 2015-04-22 | 2015-08-05 | 陈彬 | Traditional Chinese medicine composition for treating qi stagnation and blood stasis type liver cancer and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152535A (en) * | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating subacute thyroiditis |
-
2012
- 2012-11-29 CN CN201210497914.4A patent/CN103041041B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103041041A (en) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103623323A (en) | Traditional Chinese medicine for treatment of infantile malnutrition | |
CN103127293A (en) | Traditional Chinese medicine composition for treating allergic conjunctivitis | |
CN104367796A (en) | Traditional Chinese medicine composition for treating mouth ulcer | |
CN102716351A (en) | Traditional Chinese medicine electuary for clearing heat and reducing fever | |
CN103638250A (en) | Traditional Chinese medicine preparation for treating facioplegia and preparation method thereof | |
CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
CN103285271B (en) | Traditional Chinese medicine for treating internal heat type pleurisy due to yin deficiency | |
CN103083412A (en) | Traditional Chinese medicine for treating premature graying | |
CN103142879A (en) | Traditional Chinese medicine for treating rubella | |
CN103041041B (en) | Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer | |
CN103055078B (en) | Traditional Chinese medicine for treating ascites hepatoma and preparation method thereof | |
CN103041290B (en) | Traditional Chinese medicine for treating lung cancer | |
CN102688464B (en) | Traditional Chinese medicinal composition for treating atrophic gastritis and preparation method thereof | |
CN105663864A (en) | Traditional Chinese medicine preparation for gingivitis and preparation method thereof | |
CN105106837A (en) | Traditional Chinese medicine combination for treating viral hepatitis | |
CN104922403A (en) | Traditional Chinese medicine used for treating coronary heart disease | |
CN104225025A (en) | Traditional Chinese medicine bath for pruritic skin diseases of scrota and preparation method | |
CN103816436A (en) | Traditional Chinese medicine composition for treating downward flow of damp-heat | |
CN103536790A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
CN103349108A (en) | Warming-yang and tonifying-pleen healthy team cream and preparation method | |
CN104338046A (en) | Medicine for fending off cold and relieving pains | |
CN102961682B (en) | Traditional Chinese medicine composition for clearing away heat and toxic materials | |
CN102145132B (en) | Traditional Chinese medicine for treating forehead pain | |
CN103316155B (en) | Traditional Chinese medicinal composition for treating constipation and preparation method thereof | |
CN102652797A (en) | Traditional Chinese medicine decoction for treating hypertension and preparation method of traditional Chinese medicine decoction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140806 Termination date: 20151129 |
|
CF01 | Termination of patent right due to non-payment of annual fee |